• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Investigating Nucleoside Analogue Inhibition of Coronavirus Replication

    Agostini, Maria
    : https://etd.library.vanderbilt.edu/etd-10162019-171457
    http://hdl.handle.net/1803/15528
    : 2019-10-17

    Abstract

    Emerging viruses, such as coronaviruses (CoVs), continue to pose a threat to human health, and few countermeasures have been approved to treat these infections. Two CoVs have emerged to cause severe disease in humans within the last twenty years, and CoVs that are closely related to these two viruses continue to circulate in bats. Thus, new CoVs could emerge into humans to cause severe disease, emphasizing the importance of developing antivirals that broadly inhibit these viruses. This work has identified two compounds that potently inhibit CoVs: remdesivir (GS-5734) and β-D-N4-Hydroxycytidine (NHC; EIDD-1931). Both of these compounds are classified as nucleoside analogues, structural mimics of naturally occurring compounds that are required for viral replication. This work demonstrates that both of these compounds inhibit CoVs by targeting viral replication, though they do so by distinct mechanisms. In addition, remdesivir and NHC obtain only low-level resistance to the compounds after extended passage, suggesting a high barrier to resistance for both of these inhibitors. This low-level resistance in CoVs is associated with a fitness cost in the absence of drug. However, low-level resistance to one of these compounds does not broadly confer resistance to other nucleoside analogues, suggesting their potential to be used in combination to treat CoV infections. Overall, this work identifies two distinct nucleoside analogue inhibitors that potently inhibit CoVs and provide insight into CoV replication.
    Show full item record

    Files in this item

    Icon
    Name:
    Agostini.pdf
    Size:
    29.46Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy